Schaumberg D A, Dana M R, Christen W G, Glynn R J
Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Ophthalmology. 1998 Jul;105(7):1213-21. doi: 10.1016/S0161-6420(98)97023-3.
Reported rates of posterior capsule opacification (PCO) vary widely and are based on various definitions of PCO, varying lengths and intervals of follow-up, and the use of different surgical techniques, intraocular lens (i.o.l.) designs, and methods of IOL implantation. This study was designed to obtain a more precise overall estimate of the incidence of PCO and to explore factors that might influence the rate of PCO development.
A meta-analysis.
Published articles were selected for study based on a computerized MEDLINE search of the literature and a manual search of the bibliographies of relevant articles. Articles meeting selected inclusion criteria were reviewed systematically, and the reported data were abstracted and synthesized using the statistical techniques of meta-analysis.
Pooled estimates of the proportion of eyes developing PCO at three postoperative timepoints--1 year, 3 years, and 5 years--were measured.
There is significant heterogeneity among published rates of PCO. The overall pooled estimates (95% confidence limits) of the incidence of PCO were 11.8% (9.3%-14.3%) at 1 year, 20.7% (16.6%-24.9%) at 3 years, and 28.4% (18.4%-38.4%) at 5 years after surgery. There is no evidence of a significant decline in PCO incidence during the study period.
Visually significant PCO develops in more than 25% of patients undergoing standard extracapsular cataract extraction or phacoemulsification with posterior chamber intraocular lens implantation over the first 5 years after surgery. Patient characteristics, surgical techniques, and differences in research design and reporting may account for some of the variability in reported rates. However, no specific factors were identified in the authors' analysis. More precise estimates of incidence and identification of risk factors for PCO will depend on the development of a standardized measurement of PCO and wider adoption of more rigorous study methodology.
据报道,后囊膜混浊(PCO)的发生率差异很大,这是基于对PCO的各种定义、随访的不同时长和间隔,以及使用不同的手术技术、人工晶状体(IOL)设计和IOL植入方法。本研究旨在更精确地总体估计PCO的发生率,并探索可能影响PCO发生发展速率的因素。
一项荟萃分析。
基于对文献的计算机化MEDLINE检索以及对相关文章参考文献的手工检索,选择已发表的文章进行研究。对符合选定纳入标准的文章进行系统综述,并使用荟萃分析的统计技术对报告的数据进行提取和综合。
测量术后1年、3年和5年这三个时间点发生PCO的眼睛比例的合并估计值。
已发表的PCO发生率存在显著异质性。PCO发生率的总体合并估计值(95%置信区间)在术后1年为11.8%(9.3%-14.3%),3年为20.7%(16.6%-24.9%),5年为28.4%(18.4%-38.4%)。在研究期间,没有证据表明PCO发生率有显著下降。
在接受标准囊外白内障摘除术或超声乳化白内障吸除术并植入后房型人工晶状体的患者中,超过25%的患者在术后头5年内会发生具有视觉意义的PCO。患者特征、手术技术以及研究设计和报告的差异可能是报告发生率存在一些差异的原因。然而,作者的分析未确定具体因素。对PCO发生率的更精确估计以及危险因素的识别将取决于PCO标准化测量方法的开发以及更严格研究方法的更广泛采用。